查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413918

ELISpot 和 FluoroSpot 检测市场：按产品、应用和最终用户 - 2024-2030 年全球预测

ELISpot & FluoroSpot Assay Market by Product (Acessories, Analyzers, Assay Kits), Application (Autoimmune Disorders, Infectious Diseases, Oncology), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2023 年 ELISpot 和 FluoroSpot 检测市场规模为 2.9268 亿美元，2024 年将达到 3.1361 亿美元，2030 年将达到 4.7074 亿美元，复合年增长率为 7.02%。

ELISpot 和 FluoroSpot 检测的全球市场

主要市场统计
基准年[2023] 2.9268亿美元
预测年份 [2024] 31361万美元
预测年份 [2030] 47074万美元
复合年增长率（%） 7.02%
ELISpot & FluoroSpot 检测市场-IMG1

ELISpot（酵素结合免疫吸附点）测定是一种灵敏且强大的免疫检测，透过评估细胞激素分泌细胞的数量来测量细胞激素特异性T 细胞的数量。 FluoroSpot 检测可以视觉化并计算多功能 T 细胞和单一细胞激素产生细胞的数量。 FluoroSpot 检测使用不重迭的萤光标记细胞激素区分个体和共同分泌的细胞激素。 ELISPOT 和 luminousSpot 检测均广泛用于临床试验中的免疫监测，其中需要单细胞层级的定量资讯和 T 细胞表型的鑑定。世界各地慢性病盛行率的上升和生物医学研究的激增，需要引入强大的免疫学检测方法进行诊断和监测。此外，由于对个人化医疗的兴趣日益浓厚，对製药和生技领域的投资增加也扩大了这些测定的应用范围。然而，检测操作的复杂性和测试结果的可变性阻碍了该检测的普及。此外，解释测试结果的困难以及 ELISpot 和 FluoroSpot 检测资料分析的复杂性进一步使 ELISpot 和 FluoroSpot 的使用变得复杂。然而，医疗保健产业继续推动技术创新，再加上旨在提高检测特异性和准确性的研发倡议，以克服使用 ELISpot 和 FluoroSpot 检测的技术限制。随着人们对癌症和其他疾病免疫疗法的日益关注，对 ELISpot 和 FluoroSpot 检测的需求持续增长。

区域洞察

ELISpot 和 FluoroSpot 检测在美洲地区的持续成长是由成熟的医疗保健和生物技术产业、研发方面的大量投资以及主要市场参与者的存在所推动的。尤其是美国，由于其强大的医疗基础设施和不断增长的医疗支出，正在引领该地区的成长。欧洲也是 ELISpot 和 FluoroSpot 检测的关键地区之一，德国、英国、法国和义大利等国家引领了该技术的发展。欧洲的成长是由其先进的医疗保健系统和完善的研究机构所推动的。此外，学术机构和产业之间的合作正在推动检测开发的创新。欧洲市场也受益于旨在开发先进 ELISpot 和 FluoroSpot 检测的支持性监管政策。在亚太地区，由于人们对先进免疫诊断技术的认识不断提高，对慢性病的认识不断提高，以及政府旨在改善医疗保健结果的倡议，对 ELISpot 和 FluoroSpot 检测的需求不断增长。此外，该地区 CRO（委外研发机构）的存在使亚太地区成为这两种检测方法发展的关键地区。

FPNV定位矩阵

FPNV 定位矩阵对于评估 ELISpot 和 FluoroSpot 侦测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对 ELISpot 和 FluoroSpot 分析市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-ELISpot 和 FluoroSpot 检测市场的市场规模和预测是多少？

2-在 ELISpot 和 FluoroSpot 分析市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3-ELISpot 和 FluoroSpot 检测市场的技术趋势和法律规范是什么？

4-ELISpot 和 FluoroSpot 侦测市场主要供应商的市场占有率是多少？

5-进入 ELISpot 和 FluoroSpot 检测市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病及感染疾病率增加
      • 对免疫疗法和个人化医疗的需求不断增长
      • 由于免疫监测研究的增加，使用量增加
    • 抑制因素
      • 检测方案的复杂性和可变性
    • 机会
      • 使用者友善高通量检测系统的开发进展
      • ELISpot 和 FluoroSpot 检测在兽医应用中的巨大潜力
    • 任务
      • eLISpot 和 FluoroSpot 侦测解释和资料分析的复杂性
  • 市场区隔分析
    • 产品：增加研究机构和实验室对综合检测套件的支持
    • 应用：扩大政府努力推动肿瘤学研究、诊断和治疗
    • 最终用户：ELISpot 和 FluoroSpot 检测在研究和临床实践中的相关使用提供了前所未有的精确度和可靠的结果。
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第 6 章 ELISpot 和 FluoroSpot 检测市场：按产品

  • 配件
  • 分析仪
  • 检测套件

第 7 章 ELISpot 与 FluoroSpot 侦测市场：按应用分类

  • 自体免疫疾病
  • 感染疾病
  • 肿瘤学
  • 器官移植
  • 疫苗开发

第 8 章 ELISpot 和 FluoroSpot 检测市场：按最终用户划分

  • 学术研究所
  • 医院和临床实验室

第九章美洲ELISpot与FluoroSpot分析市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区ELISpot与FluoroSpot分析市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的ELISpot和FluoroSpot分析市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 新产品发布和功能增强
    • 投资、资金筹措
    • 奖项/奖励/扩展

第13章竞争产品组合

  • 主要公司简介
    • Abcam PLC
    • Abnova Corporation
    • Agilent Technologies, Inc.
    • Anogen-Yes Biotech Laboratories Ltd
    • Autoimmun Diagnostika GmbH
    • Becton, Dickinson and Company
    • Bio-Techne Corporation
    • BIOSYS Scientific Devices GmbH
    • BOC Sciences
    • Broughton Life Sciences Limited
    • CellCarta Biosciences Inc.
    • Creative Proteomics
    • Elabscience
    • Full Moon BioSystems, Inc.
    • Jackson ImmunoResearch Inc.
    • Mabtech AB
    • Merck KGaA
    • Oxford Immunotec USA, Inc.
    • Oy Medix Biochemica Ab
    • ProImmune Ltd.
    • Quansys Biosciences Inc.
    • SBH Sciences
    • U-CyTech BV
    • ZenBio, Inc.
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-961BA04A2DFB

[184 Pages Report] The ELISpot & FluoroSpot Assay Market size was estimated at USD 292.68 million in 2023 and expected to reach USD 313.61 million in 2024, at a CAGR 7.02% to reach USD 470.74 million by 2030.

Global ELISpot & FluoroSpot Assay Market

KEY MARKET STATISTICS
Base Year [2023] USD 292.68 million
Estimated Year [2024] USD 313.61 million
Forecast Year [2030] USD 470.74 million
CAGR (%) 7.02%
ELISpot & FluoroSpot Assay Market - IMG1

ELISpot (enzyme-linked immunosorbent spot) assays are sensitive and potent immunoassays that measure the quantity of antigen-specific T cells by evaluating the number of cytokine-secreting cells. FluoroSpot assays can visualize and enumerate the number of polyfunctional T cells and single-cytokine producers. FluoroSpot assay uses fluorescent labels with discrete, non-overlapping wavelengths to differentiate individual cytokines and co-secreted cytokines. Both ELISPOT and fluoroSpot assays are widely used in immuno-monitoring of clinical trials where both quantitative information and T cell phenotype identification at a single cell level are required. The rising increasing prevalence of chronic diseases across the world and a surge in biomedical research have necessitated the deployment of robust immunological assays for diagnosis and monitoring. Furthermore, the rise in investments in the pharmaceutical and biotechnology sectors, driven by a growing focus on personalized medicine, has expanded the application scope of these assays. However, the complexity of operating the assay and the chances of variability in test results impede the widespread adoption of the assays. Additionally, the difficulty of interpretation of test results and data analysis complexities with ELISpot & FluoroSpot assays further pose complications for utilization of ELISpot and FluoroSpot. However, the healthcare industry's continuous push toward innovation coupled with R&D initiatives aimed towards improving the specificity and accuracy of the assays can overcome the technical constraints of using ELISpot and FluoroSpot assay. A growing emphasis on immunotherapy treatments for cancer and other diseases further creates a significant need for ELISpot and FluoroSpot assays.

Regional Insights

The continued growth of ELISpot and FluoroSpot assays in the Americas region can be credited to its well-established healthcare and biotechnological sectors, significant investments in research and development, and the presence of major market players. Particularly, the United States, with a robust healthcare infrastructure and increased healthcare spending, is driving the growth in this region. Europe is another key region for the ELISpot and FluoroSpot assays, with countries such as Germany, the United Kingdom, France, and Italy leading the growth of the technology. The growth in Europe is driven by advanced healthcare systems and the presence of reputed research institutions. Moreover, collaborations between academic institutions and the industry foster innovation in assay development. The European market also benefits from supportive regulatory policies aimed towards the development of advanced ELISpot and FluoroSpot assays. In the APAC region, the need for ELISpot and FluoroSpot assays is expanding due to increased awareness regarding advanced immunodiagnostic techniques, increased awareness about chronic diseases, and government initiatives aimed at enhancing healthcare outcomes. Furthermore, the presence of contract research organizations (CROs) in this region positions the Asia Pacific as a prominent region for the growth of both assays.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the ELISpot & FluoroSpot Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ELISpot & FluoroSpot Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the ELISpot & FluoroSpot Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Anogen-Yes Biotech Laboratories Ltd, Autoimmun Diagnostika GmbH, Becton, Dickinson and Company, Bio-Techne Corporation, BIOSYS Scientific Devices GmbH, BOC Sciences, Broughton Life Sciences Limited, CellCarta Biosciences Inc., Creative Proteomics, Elabscience, Full Moon BioSystems, Inc., Jackson ImmunoResearch Inc., Mabtech AB, Merck KGaA, Oxford Immunotec USA, Inc., Oy Medix Biochemica Ab, ProImmune Ltd., Quansys Biosciences Inc., SBH Sciences, U-CyTech BV, and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the ELISpot & FluoroSpot Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Acessories
    • Analyzers
    • Assay Kits
  • Application
    • Autoimmune Disorders
    • Infectious Diseases
    • Oncology
    • Organ Transplantation
    • Vaccine Development
  • End-User
    • Academic Research Institutes
    • Hospitals & Clinical Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the ELISpot & FluoroSpot Assay Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the ELISpot & FluoroSpot Assay Market?

3. What are the technology trends and regulatory frameworks in the ELISpot & FluoroSpot Assay Market?

4. What is the market share of the leading vendors in the ELISpot & FluoroSpot Assay Market?

5. Which modes and strategic moves are suitable for entering the ELISpot & FluoroSpot Assay Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. ELISpot & FluoroSpot Assay Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic and infectious diseases
      • 5.1.1.2. Rising need for immunotherapy and personalized medicines
      • 5.1.1.3. Growing usage owing to an increase in immune monitoring studies
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity and variability of assay protocols
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the development of user-friendly and high-throughput assay systems
      • 5.1.3.2. High potential of eLISpot & fluoroSpot assay in veterinary applications
    • 5.1.4. Challenges
      • 5.1.4.1. Interpretation and data analysis complexities with eLISpot & fluoroSpot assays
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for comprehensive assay kits among research institutions and laboratories
    • 5.2.2. Application: Expanding government initiatives to propel oncology research, diagnosis, and therapy
    • 5.2.3. End-user: Pertaining use of ELISpot & FluoroSpot assays in research and clinical practices providing unprecedented accuracy and reliable results
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. ELISpot & FluoroSpot Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Acessories
  • 6.3. Analyzers
  • 6.4. Assay Kits

7. ELISpot & FluoroSpot Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Disorders
  • 7.3. Infectious Diseases
  • 7.4. Oncology
  • 7.5. Organ Transplantation
  • 7.6. Vaccine Development

8. ELISpot & FluoroSpot Assay Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research Institutes
  • 8.3. Hospitals & Clinical Laboratories

9. Americas ELISpot & FluoroSpot Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ELISpot & FluoroSpot Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ELISpot & FluoroSpot Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. New Product Launch & Enhancement
      • 12.3.1.1. Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing
    • 12.3.2. Investment & Funding
      • 12.3.2.1. Singamaneni to develop advanced protein imaging method
    • 12.3.3. Award, Recognition, & Expansion
      • 12.3.3.1. PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abcam PLC
    • 13.1.2. Abnova Corporation
    • 13.1.3. Agilent Technologies, Inc.
    • 13.1.4. Anogen-Yes Biotech Laboratories Ltd
    • 13.1.5. Autoimmun Diagnostika GmbH
    • 13.1.6. Becton, Dickinson and Company
    • 13.1.7. Bio-Techne Corporation
    • 13.1.8. BIOSYS Scientific Devices GmbH
    • 13.1.9. BOC Sciences
    • 13.1.10. Broughton Life Sciences Limited
    • 13.1.11. CellCarta Biosciences Inc.
    • 13.1.12. Creative Proteomics
    • 13.1.13. Elabscience
    • 13.1.14. Full Moon BioSystems, Inc.
    • 13.1.15. Jackson ImmunoResearch Inc.
    • 13.1.16. Mabtech AB
    • 13.1.17. Merck KGaA
    • 13.1.18. Oxford Immunotec USA, Inc.
    • 13.1.19. Oy Medix Biochemica Ab
    • 13.1.20. ProImmune Ltd.
    • 13.1.21. Quansys Biosciences Inc.
    • 13.1.22. SBH Sciences
    • 13.1.23. U-CyTech BV
    • 13.1.24. ZenBio, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ELISPOT & FLUOROSPOT ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ELISPOT & FLUOROSPOT ASSAY MARKET DYNAMICS
  • FIGURE 7. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ELISPOT & FLUOROSPOT ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 146. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ELISPOT & FLUOROSPOT ASSAY MARKET LICENSE & PRICING